Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells

Autor: Houssein Al-Attrache, Ziad Abdel-Razzak, Isabelle Morel, André Guillouzo, Camille C Savary, Sylvie Lepage, Ahmad Sharanek, Pamela Bachour-El Azzi, Gilles Labbe, Christiane Guguen-Guillouzo, Sébastien Anthérieu
Přispěvatelé: Foie, métabolismes et cancer, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Service des explorations fonctionnelles, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Laboratoire de Toxicologie Biologique et Médico-légale, Hôpital Pontchaillou, Sanofi-Aventis R&D, SANOFI Recherche, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Service des explorations fonctionnelles [CHU Rennes], CHU Pontchaillou [Rennes]
Jazyk: angličtina
Rok vydání: 2014
Předmět:
Zdroj: Drug Metabolism and Disposition
Drug Metabolism and Disposition, American Society for Pharmacology and Experimental Therapeutics (ASPET), 2014, 42 (9), pp.1556-66. ⟨10.1124/dmd.114.058123⟩
Drug Metabolism and Disposition, 2014, 42 (9), pp.1556-66. ⟨10.1124/dmd.114.058123⟩
ISSN: 0090-9556
1521-009X
DOI: 10.1124/dmd.114.058123⟩
Popis: International audience; Several factors are thought to be implicated in the occurrence of idiosyncratic adverse drug reactions. The present work aimed to question as to whether inflammation is a determinant factor in hepatic lesions induced by chlorpromazine (CPZ) using the human HepaRG cell line. An inflammation state was induced by a 24-hour exposure to proinflammatory cytokines interleukin-6 (IL-6) and IL-1β; then the cells were simultaneously treated with CPZ and/or cytokine for 24 hours or daily for 5 days. The inflammatory response was assessed by induction of C-reactive protein and IL-8 transcripts and proteins as well as inhibition of CPZ metabolism and down-regulation of cytochrome 3A4 (CYP3A4) and CYP1A2 transcripts, two major cytochrome P450 (P450) enzymes involved in its metabolism. Most effects of cotreatments with cytokines and CPZ were amplified or only observed after five daily treatments; they mainly included increased cytotoxicity and overexpression of oxidative stress-related genes, decreased Na(+)-taurocholate cotransporting polypeptide mRNA levels and activity, a key transporter involved in bile acids uptake, and deregulation of several other transporters. However, CPZ-induced inhibition of taurocholic acid efflux and pericanalicular F-actin distribution were not affected. In addition, a time-dependent induction of phospholipidosis was noticed in CPZ-treated cells, without obvious influence of the inflammatory stress. In summary, our results show that an inflammatory state induced by proinflammatory cytokines increased cytotoxicity and enhanced some cholestatic features induced by the idiosyncratic drug CPZ in HepaRG cells. These changes, together with inhibition of P450 activities, could have important consequences if extrapolated to the in vivo situation.
Databáze: OpenAIRE
Externí odkaz: